Lv11
60 积分 2025-06-23 加入
Semaglutide in MASH: A Promising Step Forward with Room for Improvement
6小时前
求助中
Mechanisms by Which Glucagon-Like-Peptide-1 Receptor Agonists and Sodium-Glucose Cotransporter-2 Inhibitors Reduce Cardiovascular Risk in Adults With Type 2 Diabetes Mellitus
12天前
已关闭
Glucagon‐like peptide‐1 receptor agonists and sodium‐glucose co‐transporter‐2 inhibitors as combination therapy for type 2 diabetes: A systematic review and meta‐analysis
13天前
已完结
[Chinese guideline on the primary prevention of cardiovascular diseases in primary health care]
1个月前
已完结
[Chinese expert consensus on diagnosis and management of patients with cardiovascular diseases and cognitive impairment]
1个月前
已完结
Inflammation and cholesterol as predictors of cardiovascular events among patients receiving statin therapy: a collaborative analysis of three randomised trials
1个月前
已完结
Prevalence of Chronic Kidney Disease in China
1个月前
已完结
皖公网安备34019202002308
